Cargando…
Characterising Distinct Migratory Profiles of Infiltrating T-Cell Subsets in Human Glioblastoma
Glioblastoma is the most common and aggressive form of primary brain cancer, with no improvements in the 5-year survival rate of 4.6% over the past three decades. T-cell-based immunotherapies such as immune-checkpoint inhibitors and chimeric antigen receptor T-cell therapy have prolonged the surviva...
Autores principales: | Kollis, Paris M., Ebert, Lisa M., Toubia, John, Bastow, Cameron R., Ormsby, Rebecca J., Poonnoose, Santosh I., Lenin, Sakthi, Tea, Melinda N., Pitson, Stuart M., Gomez, Guillermo A., Brown, Michael P., Gargett, Tessa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019231/ https://www.ncbi.nlm.nih.gov/pubmed/35464424 http://dx.doi.org/10.3389/fimmu.2022.850226 |
Ejemplares similares
-
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma
por: Gargett, Tessa, et al.
Publicado: (2022) -
Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy
por: Ebert, Lisa M, et al.
Publicado: (2020) -
Targeting the Sphingolipid System as a Therapeutic Direction for Glioblastoma
por: Tea, Melinda N., et al.
Publicado: (2020) -
A Drug Screening Pipeline Using 2D and 3D Patient-Derived In Vitro Models for Pre-Clinical Analysis of Therapy Response in Glioblastoma
por: Lenin, Sakthi, et al.
Publicado: (2021) -
3D-printed microplate inserts for long term high-resolution imaging of live brain organoids
por: Oksdath Mansilla, Mariana, et al.
Publicado: (2021)